Comparing genetic mutations of first-degree relatives with appendiceal pseudomyxoma peritonei may explain clinical outcomes and disease pathogenesis. Molecular profiling of mucinous tumors may identify improved treatments to traditional chemotherapy.
Keywords: appendix cancer; genetic analysis; hyperthermic intraperitoneal chemotherapy; next‐generation sequencing; pseudomyxoma peritonei.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.